235 related articles for article (PubMed ID: 36871765)
21. Case Report: Insulinoma Co-Existing With Type 2 Diabetes - Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation.
Chang JY; Woo CS; Lui DT; Fung MM; Lee AC; Leung EK; Woo YC; Chow WS; Lam KS; Tan KC; Lee CH
Front Endocrinol (Lausanne); 2022; 13():957369. PubMed ID: 35942178
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of EUS-Guided Ethanol Ablation for Treating Small Solid Pancreatic Neoplasm.
Paik WH; Seo DW; Dhir V; Wang HP
Medicine (Baltimore); 2016 Jan; 95(4):e2538. PubMed ID: 26825894
[TBL] [Abstract][Full Text] [Related]
24. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
[TBL] [Abstract][Full Text] [Related]
25. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic ultrasonography-guided tumor ablation.
Lakhtakia S; Seo DW
Dig Endosc; 2017 May; 29(4):486-494. PubMed ID: 28171697
[TBL] [Abstract][Full Text] [Related]
27. Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches.
Sada A; Ramachandran D; Oberoi M; Habermann EB; Lyden ML; Dy BM; Foster TR; Halfdanarson TR; Levy MJ; Vella A; McKenzie TJ
J Surg Res; 2024 Jan; 293():663-669. PubMed ID: 37839097
[TBL] [Abstract][Full Text] [Related]
28. EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter study.
Figueiredo Ferreira M; Garces-Duran R; Eisendrath P; Devière J; Deprez P; Monino L; Van Laethem JL; Borbath I
Endosc Int Open; 2022 Oct; 10(10):E1380-E1385. PubMed ID: 36262511
[No Abstract] [Full Text] [Related]
29. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery.
Law JK; Singh VK; Khashab MA; Hruban RH; Canto MI; Shin EJ; Saxena P; Weiss MJ; Pawlik TM; Wolfgang CL; Lennon AM
Surg Endosc; 2013 Oct; 27(10):3921-6. PubMed ID: 23636530
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports.
Rossi G; Petrone MC; Capurso G; Partelli S; Falconi M; Arcidiacono PG
World J Clin Cases; 2022 Jul; 10(19):6514-6519. PubMed ID: 35979317
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies.
Khoury T; Sbeit W; Napoléon B
World J Gastroenterol; 2023 Jan; 29(1):157-170. PubMed ID: 36683710
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series.
de Nucci G; Imperatore N; Mandelli ED; di Nuovo F; d'Urbano C; Manes G
Endosc Int Open; 2020 Dec; 8(12):E1754-E1758. PubMed ID: 33269307
[No Abstract] [Full Text] [Related]
34. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review.
Zhang L; Tan S; Huang S; Zhong C; Lü M; Peng Y; Tang X
Scand J Gastroenterol; 2020 Sep; 55(9):1121-1131. PubMed ID: 32730715
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Yan L; Zhang M; Song Q; Luo Y
Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
[No Abstract] [Full Text] [Related]
36. A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions.
Karaisz FG; Elkelany OO; Davies B; Lozanski G; Krishna SG
Diagnostics (Basel); 2023 Feb; 13(3):. PubMed ID: 36766643
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia.
Limmer S; Huppert PE; Juette V; Lenhart A; Welte M; Wietholtz H
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1097-101. PubMed ID: 19685572
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
[TBL] [Abstract][Full Text] [Related]
39. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
